PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Additionally, research indicates that NAFLD prevalence is highest among Hispanic populations, who frequently possess the PNPLA3 rs738409 risk allele, with LAP demonstrating the greatest predictive efficacy in this group (41–43).